Axsome Therapeutics Inc (AXSM)

08:36 AM

2 Top Stocks I Wouldn't Hesitate to Invest $1,000 in Right Now - MSN

08:36 AM

06:10 AM

Legato Capital Management LLC Buys New Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

06:10 AM

12:18 PM

Is Axsome Therapeutics Inc. a good long term investmentGame-changing returns - Autocar Professional

12:18 PM

Jul 23, 2025

Axsome Therapeutics (NASDAQ:AXSM) Trading Down 5.6%Here's What Happened - MarketBeat

Jul 23, 2025

Jul 23, 2025

Leerink Partners Keeps Bullish Stance on Axsome Therapeutics with Buy Rating - AInvest

Jul 23, 2025

Jul 22, 2025

Axsome Therapeutics Breaks Below 200-Day Moving AverageNotable for AXSM - Nasdaq

Jul 22, 2025

Jul 22, 2025

What drives Axsome Therapeutics Inc. stock priceUnprecedented profit potential - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Readystate Asset Management LP Invests $6.95 Million in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 22, 2025

Jul 22, 2025

Axsome Therapeutics, Inc. (NASDAQ:AXSM) is Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.'s 4th Largest Position - MarketBeat

Jul 22, 2025

Jul 22, 2025

ALKS Down Despite Positive Top-Line Data From Narcolepsy Study - The Globe and Mail

Jul 22, 2025

Jul 22, 2025

Axsome Therapeutics stock rating reiterated by Cantor Fitzgerald - Investing.com Canada

Jul 22, 2025

Jul 22, 2025

Mizuho reiterates Outperform rating on Axsome Therapeutics stock By Investing.com - Investing.com Canada

Jul 22, 2025

Jul 22, 2025

Axsome Therapeutics: Promising Growth Driven by Robust Pipeline and Strategic Fit - TipRanks

Jul 22, 2025

Jul 22, 2025

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Purchased by New York State Common Retirement Fund - MarketBeat

Jul 22, 2025

Jul 22, 2025

Lindbrook Capital LLC Sells 14,103 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 22, 2025

Jul 22, 2025

What analysts say about Axsome Therapeutics Inc. stockExtraordinary market timing - jammulinksnews.com

Jul 22, 2025

Jul 21, 2025

Axsome Therapeutics Inc. Stock Analysis and ForecastUnstoppable trading performance - Autocar Professional

Jul 21, 2025

Jul 21, 2025

Axsome Therapeutics Rings the Opening Bell - Nasdaq

Jul 21, 2025

Jul 21, 2025

Axsome Therapeutics hosts frontiers in Brain Health R&D Day - TipRanks

Jul 21, 2025

Jul 21, 2025

Axsome Therapeutics Hosts Frontiers in Brain Health R&D Day Reviewing Industry-Leading Late-Stage CNS Pipeline - Lelezard

Jul 21, 2025

Jul 21, 2025

Axsome Therapeutics: A CNS Pipeline with High-Impact Catalysts for Long-Term Growth - AInvest

Jul 21, 2025

Jul 21, 2025

Axsome Therapeutics Hosts R&D Day to Present Comprehensive Data on CNS Pipeline Targeting Alzheimer’s Disease, Depression, Narcolepsy, Fibromyalgia, ADHD, and Smoking Cessation - Nasdaq

Jul 21, 2025

Jul 21, 2025

Axsome Reveals New Phase 3 Data for 6 Major Brain Disorders: Expert Panel Discusses Breakthrough Treatments - Stock Titan

Jul 21, 2025

Jul 21, 2025

Axsome Celebrates New CNS Drug Launch with NASDAQ Bell Ringing, Unveils Brain Health Pipeline - Stock Titan

Jul 21, 2025

Jul 20, 2025

Bank of New York Mellon Corp Has $15.28 Million Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 20, 2025

Jul 20, 2025

William Blair Issues Negative Outlook for AXSM Earnings - MarketBeat

Jul 20, 2025

Jul 19, 2025

Analysts Are Bullish on These Healthcare Stocks: Axsome Therapeutics (AXSM), Enliven Therapeutics (ELVN) - The Globe and Mail

Jul 19, 2025

Jul 18, 2025

Mizuho reiterates Outperform rating on Axsome Therapeutics stock ahead of R&D Day - Investing.com Australia

Jul 18, 2025

Jul 18, 2025

Edgestream Partners L.P. Purchases New Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 18, 2025

Jul 15, 2025

Investors ignore increasing losses at Axsome Therapeutics (NASDAQ:AXSM) as stock jumps 4.5% this past week - simplywall.st

Jul 15, 2025

Jul 15, 2025

Alps Advisors Inc. Has $3.78 Million Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 15, 2025

Jul 14, 2025

(AXSM) Long Term Investment Analysis - news.stocktradersdaily.com

Jul 14, 2025

Jul 13, 2025

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Sold by Iridian Asset Management LLC CT - MarketBeat

Jul 13, 2025

Jul 11, 2025

Penserra Capital Management LLC Makes New Investment in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 11, 2025

Jul 10, 2025

Stocks Showing Improving Market Leadership: Axsome Therapeutics Earns 85 RS Rating - MSN

Jul 10, 2025

Jul 10, 2025

Morgan Stanley Assumes Coverage of Axsome Therapeutics (AXSM) with an Overweight Rating - MSN

Jul 10, 2025

Jul 09, 2025

Axsome Therapeutics (AXSM) Soars 5.77% on Positive Analyst Ratings - AInvest

Jul 09, 2025

Jul 09, 2025

Axsome Therapeutics to Showcase Its Innovative CNS Pipeline at Upcoming Frontiers in Brain Health R&D Day in New York City on July 21 - 富途牛牛

Jul 09, 2025

Jul 09, 2025

Axsome Therapeutics to Report Second Quarter 2025 Financial Results on August 4 - The Manila Times

Jul 09, 2025

Jul 09, 2025

Axsome Therapeutics Scheduled to Report Q2 2025 Financial Results and Host Conference Call on August 4, 2025 - Nasdaq

Jul 09, 2025

Jul 08, 2025

RBC Capital Reaffirms Their Buy Rating on Axsome Therapeutics (AXSM) - The Globe and Mail

Jul 08, 2025

Jul 08, 2025

Axsome Therapeutics shares rise 1.08% intraday as RBC Capital Markets maintains its stance on the biopharma company. - AInvest

Jul 08, 2025

Jul 08, 2025

Axsome Therapeutics (AXSM) Initiated with a Buy at Oppenheimer - The Globe and Mail

Jul 08, 2025

Jul 08, 2025

Axsome Therapeutics (AXSM) Gets a Buy from Wells Fargo - The Globe and Mail

Jul 08, 2025

Jul 08, 2025

RBC Capital Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Cuts Target Price to $184 - 富途牛牛

Jul 08, 2025

Jul 07, 2025

Piper Sandler Reaffirms Price Target on Axsome (AXSM) Despite AXS-14 FDA Hurdle - MSN

Jul 07, 2025